解剖病理学の世界市場予測：機器（組織処理システム、ミクロトーム）、消耗品（抗体）、組織病理学...市場調査レポートについてご紹介

1 Introduction (Page No. – 21)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. – 25)
2.1 Research Data
2.2 Secondary Data
2.2.1 Secondary Sources
2.3 Primary Data
2.4 Market Size Estimation
2.4.1 Bottom-Up Approach
2.4.1.1 Bottom-Up Approach for the Instruments and Consumables Market
2.4.2 Top-Down Approach
2.4.2.1 Services Market Estimation Based on Number of Tests
2.4.2.2 Services Market Estimation Based on Procedures
2.4.3 Growth Forecast
2.5 Market Breakdown and Data Triangulation
2.6 Assumptions for the Study
3 Executive Summary (Page No. – 33)
3.1 Introduction
4 Premium Insights (Page No. – 37)
4.1 Anatomic Pathology: Market Overview
4.2 North America: Anatomic Pathology Market, By Product & Service
4.3 Geographical Snapshot of the Market
5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Incidence of Cancer and Other Target Diseases
5.2.1.2 Recommendations for Cancer Screening
5.2.1.3 Availability of Reimbursement
5.2.1.4 Growing Focus on Personalized Medicine
5.2.2 Opportunities
5.2.2.1 Emerging Economies
5.2.3 Challenges
5.2.3.1 Availability of Refurbished Products
5.2.3.2 Lack of Skilled Professionals
5.2.3.3 Product Failures and Recalls
5.2.4 Trends
5.2.4.1 Reagent Rental Agreements
6 Anatomic Pathology Market, By Product & Service (Page No. – 45)
6.1 Introduction
6.2 Services
6.2.1 Histopathology
6.2.1.1 the Majority of Cancers are Diagnosed Via Histopathology—A Key Factor Driving Market Growth
6.2.2 Cytopathology
6.2.2.1 Government Focus on Cervical Cancer Screening has Boosted the Growth of the Cytopathology Services Market
6.3 Consumables
6.3.1 Antibodies
6.3.1.1 Primary Antibodies
6.3.1.1.1 North America Dominates the Primary Antibodies Market
6.3.1.2 Secondary Antibodies
6.3.1.2.1 Asia Pacific Will Show the Highest Growth in the Market for Secondary Antibodies
6.3.2 Kits & Reagents
6.3.2.1 Stains & Solvents
6.3.2.1.1 North America Accounted for Highest Share in This Market
6.3.2.2 Fixatives
6.3.2.2.1 North America Accounts for the Largest Share of the Fixatives Market
6.3.2.3 Other Kits & Reagents
6.3.3 Probes
6.3.3.1 APAC is Expected to Show the Highest Growth in the Probes Market
6.3.4 Other Consumables
6.4 Instruments
6.4.1 Slide Staining Systems
6.4.1.1 Availability of Automated Systems Will Drive Market Growth During the Forecast Period
6.4.2 Tissue Processing Systems
6.4.2.1 Rising Adoption of Automation is a Key Trend in the Tissue Processing Systems Market
6.4.3 Cell Processors
6.4.3.1 Cell Processors are Used to Remove Unwanted Matter in Samples—Making Them Important Instruments in the Market
6.4.4 Microtomes
6.4.4.1 North America Accounts for the Largest Share of the Microtomes Market
6.4.5 Embedding Systems
6.4.5.1 Asia Pacific is Expected to Register the Highest Growth During the Forecast Period
6.4.6 Coverslippers
6.4.6.1 Coverslippers are Widely Used Instruments in Research Alongside Staining Systems
6.4.7 Other Instruments
7 Anatomic Pathology Market, By Application (Page No. – 60)
7.1 Introduction
7.2 Disease Diagnostics
7.2.1 Cancer
7.2.1.1 Breast Cancer
7.2.1.1.1 Breast Cancer Holds the Highest Mortality Rate Among Cancers in North America
7.2.1.2 Gastrointestinal Cancer
7.2.1.2.1 North America Accounts for the Largest Share of the Market for Gastrointestinal Cancer
7.2.1.3 Lung Cancer
7.2.1.3.1 Lung Cancer is the Most Common Cancer in the World
7.2.1.4 Prostate Cancer
7.2.1.4.1 Prostate is the Third-Leading Cause of Death By Cancer in North America
7.2.1.5 Other Cancers
7.2.2 Other Diseases
7.3 Medical Research
7.3.1 Growing Research Activities Will Drive the Adoption of Anatomic Pathology Products in This Application Segment
8 Anatomic Pathology Market, By End User (Page No. – 69)
8.1 Introduction
8.2 Hospital Laboratories
8.2.1 Hospital Laboratories Accounted for the Largest Share of the Market
8.3 Clinical Laboratories
8.3.1 Increasing Outpatient Surgeries to Drive the Growth of This Segment
8.4 Other End Users
9 Anatomic Pathology Market, By Region (Page No. – 74)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 The US Dominates the Global Market
9.2.2 Canada
9.2.2.1 High Burden of Cancer to Support Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Availability of Reimbursement for Colorectal Cancer Screening to Support Market Growth
9.3.2 France
9.3.2.1 Government Funding for Cancer Diagnosis & Prevention to Support Market Growth
9.3.3 UK
9.3.3.1 Government Initiatives to Drive Market Growth in the UK
9.3.4 Italy
9.3.4.1 High Incidence of Cancer and Increasing Per Capita Healthcare Spending to Support Market Growth in Italy
9.3.5 Spain
9.3.5.1 High Incidence of Chronic Diseases to Drive the Spanish Market
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Presence of a Well-Developed Healthcare System to Support Market Growth in Japan
9.4.2 China
9.4.2.1 Rising Healthcare Expenditure to Drive the Market Growth
9.4.3 India
9.4.3.1 Growing Healthcare Sector in the Country to Drive Market Growth
9.4.4 Rest of Asia Pacific
9.5 Rest of the World
9.5.1 Latin America
9.5.1.1 Cancer Screening Programs to Support Market Growth
9.5.2 Middle East & Africa
9.5.2.1 Increasing Incidence of Cancer in Africa to Support Market Growth
10 Competitive Landscape (Page No. – 143)
10.1 Overview
10.2 Market Share Analysis, 2018
10.3 Competitive Scenario
10.3.1 Agreements & Partnerships (2016–2019)
10.3.2 Expansions (2016–2019)
10.3.3 Product Launches & Approvals (2016–2019)
10.3.4 Acquisitions (2016–2019)
10.4 Competitive Leadership Mapping (2019)
10.4.1 Vendor Inclusion Criteria
10.4.2 Visionary Leaders
10.4.3 Innovators
10.4.4 Dynamic Differentiators
10.4.5 Emerging Companies
11 Company Profiles (Page No. – 150)
11.1 F. Hoffman-La Roche Ltd.
11.1.1 Business Overview
11.1.2 Products Offered
11.1.3 MnM View
11.2 Danaher
11.2.1 Business Overview
11.2.2 Products Offered
11.2.3 Recent Developments
11.2.4 MnM View
11.3 Thermo Fisher Scientific
11.3.1 Business Overview
11.3.2 Products Offered
11.3.3 Recent Developments
11.3.4 MnM View
11.4 Abcam PLC.
11.4.1 Business Overview
11.4.2 Products Offered
11.4.3 Recent Developments
11.5 Hologic, Inc.
11.5.1 Business Overview
11.5.2 Products Offered
11.5.3 Recent Developments
11.6 Agilent Technologies
11.6.1 Business Overview
11.6.2 Products Offered
11.7 Becton, Dickinson and Company
11.7.1 Business Overview
11.7.2 Products Offered
11.7.3 Recent Developments
11.7.4 MnM View
11.8 Sakura Finetek USA Inc.
11.8.1 Business Overview
11.8.2 Products Offered
11.8.3 Recent Developments
11.9 Merck KGaA
11.9.1 Business Overview
11.9.2 Products Offered
11.9.3 Recent Developments
11.10 Bio SB
11.10.1 Business Overview
11.10.2 Products Offered
11.10.3 Recent Developments
11.11 BioGenex
11.11.1 Business Overview
11.11.2 Products Offered
11.12 Milestone Medical
11.12.1 Business Overview
11.12.2 Products Offered
11.13 Histo-Line Laboratories
11.13.1 Business Overview
11.13.2 Products Offered
11.13.3 Recent Developments
11.14 Diapath S.P.A.
11.14.1 Business Overview
11.14.2 Products Offered
11.14.3 Recent Developments
11.15 Slee Medical GmbH
11.15.1 Business Overview
11.15.2 Products Offered
11.16 Amos Scientific Pty Ltd
11.16.1 Business Overview
11.16.2 Products Offered
11.17 Medite GmbH
11.17.1 Business Overview
11.17.2 Products Offered
11.18 Cell Signaling Technology
11.18.1 Business Overview
11.18.2 Products Offered
11.18.3 Recent Developments
11.19 CeLLPath Ltd.
11.19.1 Business Overview
11.19.2 Products Offered
11.20 Jinhua Yidi Medical Appliance Co. Ltd
11.20.1 Business Overview
11.20.2 Products Offered
12 Appendix (Page No. – 186)
12.1 Insights From Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details